SISevil İrIşli

Sevil İrIşli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sevil İrIşli has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Çağdaş Kimya Araştırmaları ve Multidisipliner Uygulamaları-Contemporary Chemistry Research and Multidisciplinary Applications

    by Abdolahi M. Adawe, Tufan Güray, Gülmira Özek, Ülkü Dilek Uysal, Ömer Koray Yaylacı, Temel Özek, Bingül Kurt Urhan, Mesut Eryiğit, Burcu Bozkurt Çırak, Çiğdem Eden, et al.

    Kimya, günümüzde maddenin yapısını ve dönüşümlerini inceleyen temel bir bilim dalı olmanın ötesinde; enerji, sağlık, çevre ve malzeme teknolojileri gibi pek çok alandaki bilimsel ve teknolojik gelişmelere yön veren disiplinler arası bir araştırma alanı olarak öne çıkmaktadır. Farklı bilim dallarıyla kurduğu güçlü etkileşim sayesinde kimya, çağımızın karmaşık sorunlarına yenilikçi ve sürdürülebilir çözümler geliştirilmesinde önemli bir rol üstlenmektedir. Çağdaş Kimya Araştırmaları ve Multidisipliner Uygulamaları, güncel kimya araştırmalarını ve bu araştırmaların farklı disiplinlerdeki uygulamalarını bütüncül bir perspektifle ele almaktadır. Alanında uzman akademisyen ve araştırmacıların katkılarıyla hazırlanan 16 özgün bölümden oluşan bu eser; • Yeşil kimya ve sürdürülebilir kimyasal süreçleri, • Biyomedikal ve farmasötik kimya alanındaki gelişmeleri, • Nanomalzemeler ve ileri malzeme teknolojilerini, • Yenilikçi enerji depolama sistemlerini, • Gelişmiş analitik yöntemleri ve güncel uygulamaları kapsayan geniş bir araştırma yelpazesi sunmaktadır. Bilimsel bilgi birikimini güncel araştırma yaklaşımlarıyla buluşturan bu eser; akademisyenler, araştırmacılar ve lisansüstü öğrenciler için nitelikli bir başvuru kaynağı olmasının yanı sıra, kimyanın farklı disiplinlerle kurduğu ilişkileri ve sunduğu yeni araştırma olanaklarını keşfetmek isteyen okuyuculara da kapsamlı bir perspektif kazandırmayı amaçlamaktadır. Maddenin gizeminden bilimsel yeniliklere, bugünün araştırmalarından geleceğin teknolojilerine uzanan bir keşif yolculuğu…

  • Advanced resin-based composites reinforced with modified montmorillonite

    by Elçin Ünver, Sevil İrIşli

    The primary objective of this study was to develop novel resin-based dental composites reinforced with modified sodium montmorillonite (MMT) and to determine the structural and physicochemical properties of these composites. A mixture of barium glass, silica, and MMT was used as the filler system. The organic matrix was based on the monomers Bis-EMA, TEGDMA, and UDMA. MMT was modified using 3-methacryloxypropyltrimethoxysilane (γ-MPS) and cetyltrimethylammonium bromide (CTAB), resulting in two groups of composites. The optimal formulation was determined as 70 wt% filler (7.5 wt% clay) and 30 wt% monomer content. Comprehensive characterization was performed using XRD, SEM, FTIR, and TGA. Mechanical and physical properties were assessed according to ISO 4049 standards, including flexural strength, degree of conversion, depth of cure, water sorption & solubility, polymerization shrinkage, and radiopacity. The results demonstrated that organo-modified MMT enhanced interfacial compatibility between the resin matrix and the filler, enabling uniform dispersion and improved performance. Among the prepared composites, two formulations met the ISO 4049 requirements and showed promising potential for structural intraoral applications. In addition to its favorable interfacial behavior, MMT’s low cost and natural abundance make it a practical alternative to conventional fillers in dental composite systems.


  • Novel Schiff base-Pt( ii ) complexes: inhibition of Aβ aggregation via histidine interaction

    by Sevil İrIşli, Umut Doğan, Salih Günnaz, Fatma Yurt, Onur Şahin

    Three novel Schiff base–Pt( ii ) complexes were synthesized and characterized. Complexes I and III showed significant anti-amyloid activity by inhibiting Aβ 1–42 peptide aggregation in vitro , with potential to cross the blood–brain barrier.


  • Open Access

    The Amyloid Beta Aggregation Inhibition Properties of New Pt (II) Complexes and Their Potential in Alzheimer's Treatment

    by Salih Günnaz, Onur Şahin, Sevil İrIşli

    In this study, N‐phenylortho‐phenylenediamine and N‐phenyl ethylenediamine were utilized as amines, and two novel ligands, benzimidazole (LI) and Schiff base (LII), were synthesized through condensation reactions with 3‐methoxy‐4‐benzyloxybenzaldehyde. Furthermore, using these same amines, LIII (benzimidazole) with 3‐phenoxybenzaldehyde and LIV (Schiff base) with 4‐benzyloxybenzaldehyde were synthesized in accordance with the literature. Then, Pt (II) complexes (Ia, Ib, II, III, and IV) were prepared with these ligands, and it was determined that Ia and Ib are geometric isomers. The ligands and complexes were characterized using 1H‐NMR, 13C‐NMR, FT‐IR, and elemental analysis methods. The cytotoxic effects of these complexes were evaluated on SH‐SY5Y neuronal cells. Low‐toxicity complexes Ia, II, and IV were then tested for their ability to inhibit amyloid beta (Aβ1–42) aggregation. Thioflavin T fluorescence analysis, AFM imaging, and MALDI‐TOF mass spectrometry demonstrated that these complexes, particularly at a 1:1 complex‐to‐amyloid molar ratio, effectively inhibited Aβ aggregation. These findings suggest that Pt (II) complexes containing Schiff base and benzimidazole ligands may be effective against Alzheimer's disease by alleviating Aβ toxicity.


  • New Schiff Base and Its Platinum Complex: Inhibition of Amyloid Aggregation

    by Özge Özcan, Salih Günnaz, Sevil İrIşli

    This study investigates the synthesis and characterization of a Schiff base (L) comprising amine and imine donor atoms, specifically N1-(4-(benzyloxy)benzylidene)-N2-phenylethane-1,2-diamine, along with its Platinum(II) complex (Pt-L). The structural elucidation of both the ligand and complex is accomplished through various spectroscopic techniques including Fourier-transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (1H-NMR), carbon-13 nuclear magnetic resonance (13C-NMR), and elemental analysis. Furthermore, the potential inhibitory effects of the Pt-L complex on Aβ1-42 aggregation are explored using the human neuroblastoma cell line (SH-SY5Y) as a model system. The cytotoxicity of the Pt-L complex on SH-SY5Y neuroblastoma cells is examined, revealing an IC50 value of 19.22 μM. The inhibition kinetics of Aβ aggregation are also investigated fluorometrically using Thioflavine-T. By analyzing the area under the curve, it is calculated that the complex (1.0:1.0 molar ratio) interacts with amyloid at a rate of 65%. These results obtained in our study show that the complex is promising in terms of inhibition of Aβ1-42.

  • Open Access

    Evaluation of Pro-Drug Properties in a Novel Schiff Base-Incorporated Pt(II) Complex

    by Salih Günnaz, Khan Mohammad Rahmat, Sevil İrIşli

    The present investigation involved the synthesis of a new Schiff base and its platinum complex. The chemical structures of both the ligand and the complex were determined through the utilization of various analytical techniques, including 1H-NMR, 13C-NMR, FT-IR, and elemental analysis. Moreover, the interaction between the synthesized complex and Amyloid-Beta, a crucial factor in the pathogenesis of Alzheimer's disease, was explored. This interaction was assessed by means of fluorescence spectrophotometry. Additionally, the influence of the histidine amino acid, which has been reported in the literature to play a significant role in the interaction between Amyloid-Beta and coordination compounds, was monitored using 1H-NMR. These investigations have the potential to enhance our comprehension of the chemical structure and biological effects of ligands and complexes. Furthermore, they may contribute to the advancement of knowledge regarding important neurodegenerative disorders such as Alzheimer's disease, as well as the development of potential therapeutic strategies.

  • Open Access

    Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

    by Sevil İrIşli, Salih Günnaz, Özge Özcan, Aydan Arı, Meltem Maral, Arzum Erdem, Derya Özel, Fatma Yurt

    For synthesizing metal–organic molecules with pro‐drug properties to prevent the accumulation of amyloid beta (Aβ1–42), which is a feature of neurodegenerative Alzheimer's disease, two new Schiff bases with imine/amine donors 2‐([3,3‐diphenylalidene]amino)‐N,N‐dimethylethane‐1‐amine and N,N‐dimethyl‐2‐([quinolin‐4‐ylmethylene]amino)ethane‐1‐amine, as well as their novel Pt (II) complexes (I and II), were synthesized and characterized via Fourier transform infrared spectroscopy, 1H‐ and 13C‐nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and elemental analyses. The spectroscopic data has shown that the ligands are coordinated to the central atom in a chelating manner.Furthermore, the interaction between these complexes and Aβ1–42 was investigated using the electrochemical methods, square wave voltammetry and pencil graphite electrode, while monitoring the changes in the oxidation signal of the Try residue in Aβ1–42.The ability of the compounds to inhibit Aβ1–42 aggregation was investigated using the human neuroblastoma cell line (SH‐SY5Y). Complex II could actively inhibit the aggregation of Aβ1–42 at a molar ratio of 1.0/1.0, and its Aβ1–42 aggregation kinetics were fluorometrically determined using thioflavin T.These results were supported by scanning electron microscopy and transmission electron microscopy analyses. Moreover, the interaction of complex II with Aβ1–16 was investigated via 1H‐NMR spectroscopy.As a result, it was observed that complex II was effective in inhibiting the aggregation of Aβ1–42 at a molar ratio of 1.0/1.0. This result shows that studies can be conducted on the effects of Schiff base‐Pt complexes as potential pro‐drugs on Alzheimer's disease.


  • Benzimidazole-Platinum Complex and Its Cytotoxic activity on U87 Cell Lines

    by Aydan Arı, Salih Günnaz, Sevil İri̇şli̇

    Çalışmanın amacı, güçlü sitotoksik aktiviteye ve düşük yan etkilere sahip olabilen yeni bir benzimidazol-platin(II) kompleksinin sentezi, karakterizasyonu ve sitotoksik aktivitelerinin değerlendirilmesidir. Bir benzimidazol ligandı, 2-(3-fenoksifenil)-1-fenil-1H-benzimidazol (L) ve bunun yeni platin kompleksi (Pt-L), sentezlenmiş yapıları farklı spektroskopik yöntemlerle karakterize edilmiştir. Çalışmada, sentezlenen kompleksin öncelikle U87 kanser hattındaki aktivitesi incelenmiş, daha sonra sağlıklı Vero hatları üzerinde çalışılmıştır.